Health-Related Quality of Life of Non-Small Cell Lung Cancer Patients Treated with Targeted Therapy: Based on the EQ-5D-5L Scale in Vietnam.

Objective: Non-small cell lung cancer (NSCLC) patients can prolong their life owing to targeted therapy. Assessing patients' quality of life (QOL) can help improve QOL and prolong their lives.

Methods: A cross-sectional study was conducted at the Department of Medical Oncology 1 and Medical Oncology 2, Vietnam National Cancer Hospital in Tan Trieu, Hanoi, Vietnam, from October 2022 to December 2023 on the basis of the EQ-5D-5L scale to identify the QOL of 310 patients with NSCLC who were treated with first-line targeted therapy.

Effectiveness and Tolerability of First-Line Afatinib for Advanced EGFR-Mutant Non-Small Cell Lung Cancer in Vietnam.

Background: We aimed to evaluate the effectiveness and tolerability of Afatinib as first-line treatment of advanced epidermal growth factor receptor (EGFR) mutant non small cell lung cancer (NSCLC) in a real-world setting.

Patients And Methods: This is a retrospective study of Vietnamese patients  with advanced EGFR-mutant NSCLC treated with first-line afatinib at the National Cancer Hospital from 1st January 2018 to 31st October 2020. Patients' demographic, clinical and treatment data were captured.